Dynamic expression of leukocyte innate immune genes in whole blood from horses with lipopolysaccharide-induced acute systemic inflammation

BMC Veterinary Research

Pia H Andersen³  Peter MH Heegaard¹  Kerstin Skovgaard¹  Anne Mette L Vinther² 

[1] Innate Immunology Group, Section for Immunology and Vaccinology, National Veterinary Institute, Technical University of Denmark, Frederiksberg, Denmark;Department of Large Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Taastrup, Denmark;Department of Clinical Sciences, Faculty of Veterinary and Animal Science, Swedish University of Agricultural Sciences, Uppsala, Sweden

关键词: Time course study;    Systemic inflammation;    Lipopolysaccharide;    Leukocytes;    Innate immunity;    Gene expression dynamics;    Equine;    Endotoxemia;    Cytokines;    Baseline expression variability;   

Others  :  1219138
DOI  :  10.1186/s12917-015-0450-5

 received in 2014-12-22, accepted in 2015-06-02,  发布年份 2015

【 摘 要 】

Background

In horses, insights into the innate immune processes in acute systemic inflammation are limited even though these processes may be highly important for future diagnostic and therapeutic advances in high-mortality disease conditions as the systemic inflammatory response syndrome (SIRS) and sepsis. Therefore, the aim of this study was to investigate the expression of 31 selected blood leukocyte immune genes in an equine model of acute systemic inflammation to identify significantly regulated genes and to describe their expression dynamics during a 24-h experimental period. Systemic inflammation was induced in 6 adult horses by the intravenous injection of 1 μg lipopolysaccharide (LPS) per kg btw. Sixteen blood samples were collected for each horse at predetermined intervals and analyzed by reverse transcription quantitative real-time PCR. Post-induction expression levels for each gene were compared with baseline levels.

Results

Systemic inflammation was confirmed by the presence of clinical and hematological changes which were consistent with SIRS. The clinical response to LPS was transient and brief as all horses except one showed unaltered general demeanor after 24 h. Twenty-two leukocyte genes were significantly regulated at at least one time point during the experimental period. By close inspection of the temporal responses the dynamic changes in mRNA abundance revealed a very rapid onset of both pro- and anti-inflammatory mediators and a substantial variation in both expression magnitudes and duration of changes between genes. A majority of the 22 significantly regulated genes peaked within the first 8 h after induction, and an on-going, albeit tightly controlled, regulation was seen after 24 h despite approximate clinical recovery.

Conclusions

This first broad study of gene expressions in blood leukocytes during equine acute LPS-induced systemic inflammation thoroughly characterized a highly regulated and dynamic innate immune response. These results provide new insights into the molecular mechanisms of equine systemic inflammation.

【 授权许可】

   
2015 Vinther et al.

【 图 表 】

Fig. 1.

【 参考文献 】

• [1]Mackay RJ. Endotoxemia. In P. SB editor, Large Animal Internal Medicine. 4. edn. St. Louis, Missouri: Mosby Elsevier; 2009: 711–23.
• [2]Cohen J. The immunopathogenesis of sepsis. Nature. 2002; 420(6917):885-91.
• [3]van der Poll T, Opal SM. Host-pathogen interactions in sepsis. Lancet Infect Dis. 2008; 8(1):32-43.
• [4]Gustot T. Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response. Curr Opin Crit Care. 2011; 17(2):153-9.
• [5]Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA et al.. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992; 101(6):1644-55.
• [6]Werners AH, Bull S, Fink-Gremmels J. Endotoxaemia: a review with implications for the horse. Equine Vet J. 2005; 37(4):371-83.
• [7]Pusterla N, Magdesian KG, Mapes S, Leutenegger CM. Expression of molecular markers in blood of neonatal foals with sepsis. Am J Vet Res. 2006; 67(6):1045-9.
• [8]Castagnetti C, Mariella J, Pirrone A, Cinotti S, Mari G, Peli A. Expression of interleukin-1beta, interleukin-8, and interferon-gamma in blood samples obtained from healthy and sick neonatal foals. Am J Vet Res. 2012; 73(9):1418-27.
• [9]Gold JR, Cohen ND, Welsh TH. Association of adrenocorticotrophin and cortisol concentrations with peripheral blood leukocyte cytokine gene expression in septic and nonseptic neonatal foals. J Vet Intern Med. 2012; 26(3):654-61.
• [10]Gold JR, Perkins GA, Erb HN, Ainsworth DM. Cytokine profiles of peripheral blood mononuclear cells isolated from septic and healthy neonatal foals. J Vet Intern Med. 2007; 21(3):482-8.
• [11]Burton AB, Wagner B, Erb HN, Ainsworth DM. Serum interleukin-6 (IL-6) and IL-10 concentrations in normal and septic neonatal foals. Vet Immunol Immunopathol. 2009; 132(2–4):122-8.
• [12]Lopes MA, Salter CE, Vandenplas ML, Berghaus R, Hurley DJ, Moore JN. Expression of inflammation-associated genes in circulating leukocytes collected from horses with gastrointestinal tract disease. Am J Vet Res. 2010; 71(8):915-24.
• [13]Nieto JE, MacDonald MH, Braim AE, Aleman M. Effect of lipopolysaccharide infusion on gene expression of inflammatory cytokines in normal horses in vivo. Equine Vet J. 2009; 41(7):717-9.
• [14]Fossum C, Hjertner B, Olofsson KM, Lindberg R, Ahooghalandari P, Camargo MM et al.. Expression of tlr4, md2 and cd14 in equine blood leukocytes during endotoxin infusion and in intestinal tissues from healthy horses. Vet Immunol Immunopathol. 2012; 150(3–4):141-8.
• [15]Tadros EM, Frank N. Effects of continuous or intermittent lipopolysaccharide administration for 48 hours on the systemic inflammatory response in horses. Am J Vet Res. 2012; 73(9):1394-402.
• [16]Henneke DR, Potter GD, Kreider JL, Yeates BF. Relationship between condition score, physical measurements and body fat percentage in mares. Equine Vet J. 1983; 15(4):371-2.
• [17]Aiello SEE. The Merck veterinary manual. 8th ed. Merck & Co., Inc, Whitehouse Station, N. J., USA; 1998.
• [18]Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M et al.. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol. 2006; 7:3. BioMed Central Full Text
• [19]Skovgaard K, Cirera S, Vasby D, Podolska A, Breum SO, Durrwald R et al.. Expression of innate immune genes, proteins and microRNAs in lung tissue of pigs infected experimentally with influenza virus (H1N2). Innate Immun. 2013; 19(5):531-44.
• [20]Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004; 64(15):5245-50.
• [21]Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome biology. 2002, 3(7). RESEARCH0034.
• [22]Moore JN, Norton N, Barton MH, Hurley DJ, Reber AJ, Donovan DC et al.. Rapid infusion of a phospholipid emulsion attenuates the effects of endotoxaemia in horses. Equine Vet J. 2007; 39(3):243-8.
• [23]Morris DD, Moore JN, Crowe N, Moldawer LL. Effect of experimentally induced endotoxemia on serum interleukin-6 activity in horses. Am J Vet Res. 1992; 53(5):753-6.
• [24]Wearn JG, Suagee JK, Crisman MV, Corl BA, Hulver MW, Hodgson DR et al.. Effects of the insulin sensitizing drug, pioglitazone, and lipopolysaccharide administration on markers of systemic inflammation and clinical parameters in horses. Vet Immunol Immunopathol. 2012; 145(1–2):42-9.
• [25]Baskett A, Barton MH, Norton N, Anders B, Moore JN. Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses. Am J Vet Res. 1997; 58(11):1291-9.
• [26]Jacobs CC, Holcombe SJ, Cook VL, Gandy JC, Hauptman JG, Sordillo LM. Ethyl pyruvate diminishes the inflammatory response to lipopolysaccharide infusion in horses. Equine Vet J. 2013; 45(3):333-9.
• [27]Fessler JF, Bottoms GD, Coppoc GL, Gimarc S, Latshaw HS, Noble JK. Plasma endotoxin concentrations in experimental and clinical equine subjects. Equine Vet J Suppl. 1989; 7:24-8.
• [28]Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ et al.. A network-based analysis of systemic inflammation in humans. Nature. 2005; 437(7061):1032-7.
• [29]Talwar S, Munson PJ, Barb J, Fiuza C, Cintron AP, Logun C et al.. Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans. Physiol Genomics. 2006; 25(2):203-15.
• [30]McLoughlin K, Turteltaub K, Bankaitis-Davis D, Gerren R, Siconolfi L, Storm K et al.. Limited dynamic range of immune response gene expression observed in healthy blood donors using RT-PCR. Mol Med. 2006; 12(7–8):185-95.
• [31]Wong HR. Genetics and genomics in pediatric septic shock. Crit Care Med. 2012; 40(5):1618-26.
• [32]Prabhakar U, Conway TM, Murdock P, Mooney JL, Clark S, Hedge P et al.. Correlation of protein and gene expression profiles of inflammatory proteins after endotoxin challenge in human subjects. DNA Cell Biol. 2005; 24(7):410-31.
• [33]de Sousa AR, Penalva LO, Marcotte EM, Vogel C. Global signatures of protein and mRNA expression levels. Mol Biosyst. 2009; 5(12):1512-26.
• [34]Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet. 2012; 13(4):227-32.
• [35]Hollams EM, Giles KM, Thomson AM, Leedman PJ. MRNA stability and the control of gene expression: implications for human disease. Neurochem Res. 2002; 27(10):957-80.
• [36]Tadros EM, Frank N, Donnell RL. Effects of equine metabolic syndrome on inflammatory responses of horses to intravenous lipopolysaccharide infusion. Am J Vet Res. 2013; 74(7):1010-9.
• [37]Fry DE. Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues. Am Surg. 2012; 78(1):1-8.
• [38]Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol. 1997; 74(2):111-22.
• [39]Gaur U, Aggarwal BB. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol. 2003; 66(8):1403-8.
• [40]De Freitas I, Fernandez-Somoza M, Essenfeld-Sekler E, Cardier JE. Serum levels of the apoptosis-associated molecules, tumor necrosis factor-alpha/tumor necrosis factor type-I receptor and Fas/FasL, in sepsis. Chest. 2004; 125(6):2238-46.
• [41]Turrel-Davin F, Guignant C, Lepape A, Mougin B, Monneret G, Venet F. Upregulation of the pro-apoptotic genes BID and FAS in septic shock patients. Crit Care. 2010; 14(4):R133. BioMed Central Full Text
• [42]Weber SU, Schewe JC, Lehmann LE, Muller S, Book M, Klaschik S et al.. Induction of Bim and Bid gene expression during accelerated apoptosis in severe sepsis. Crit Care. 2008; 12(5):R128. BioMed Central Full Text
• [43]Vallet B. Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction? Crit Care. 2003; 7(2):130-8. BioMed Central Full Text
• [44]Satué K, Muñoz A, Gardón JC. Interpretation of the equine leukogram. J Hematology Res. 2014; 1(1):27-35.
• [45]Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA et al.. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A. 2003; 100(4):1896-901.
• [46]Eady JJ, Wortley GM, Wormstone YM, Hughes JC, Astley SB, Foxall RJ et al.. Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiol Genomics. 2005; 22(3):402-11.
• [47]Skibsted S, Bhasin MK, Aird WC, Shapiro NI. Bench-to-bedside review: Future novel diagnostics for sepsis - a systems biology approach. Crit Care. 2013; 17(5):231. BioMed Central Full Text
• [48]Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care. 2010; 14(1):R15. BioMed Central Full Text
• [49]Sutherland A, Thomas M, Brandon RA, Brandon RB, Lipman J, Tang B et al.. Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis. Crit Care. 2011; 15(3):R149. BioMed Central Full Text
• [50]Andaluz-Ojeda D, Bobillo F, Iglesias V, Almansa R, Rico L, Gandia F et al.. A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis. Cytokine. 2012; 57(3):332-6.
• [51]Wong HR, Lindsell CJ, Pettila V, Meyer NJ, Thair SA, Karlsson S et al.. A multibiomarker-based outcome risk stratification model for adult septic shock. Crit Care Med. 2014; 42(4):781-9.
• [52]Declue AE, Johnson PJ, Day JL, Amorim JR, Honaker AR. Pathogen associated molecular pattern motifs from Gram-positive and Gram-negative bacteria induce different inflammatory mediator profiles in equine blood. Vet J. 2012; 192(3):455-60.